Homology Medicines, Inc. Soared
Fri, Jul 28, 2023 at 07:41 PM
Homology Medicines, Inc. (FIXX:NASDAQ) soared at $1.33, representing a gain of 41.5%. On Fri, Jul 28, 2023, FIXX:NASDAQ hit a New 2-Week High of $1.33. The stock got featured on our News Catalysts scanner on Thu, Jul 27, 2023 at 06:15 PM in the 'BIOTECH' category. From Fri, Jul 14, 2023, the stock recorded 50.00% Up Days and 36.36% Green Days
About Homology Medicines, Inc. (FIXX:NASDAQ)
Homology Medicines is an US based genetic medicines company. It is dedicated towards translating proprietary, cutting-edge gene editing and gene therapy technology into cures for patients with rare diseases.
Top 10 Gainers:
- Viveve Medical, Inc. (VIVE:NASDAQ), 118.75%
- Aurora Acquisition Corp. (AURC:NASDAQ), 113.21%
- Unique Fabricating, Inc. (UFAB:NYSEMKT), 60.19%
- Colombier Acquisition Corp. Class A (CLBR:NYSE), 54.51%
- Reata Pharmaceuticals, Inc. (RETA:NASDAQ), 54.02%
- Bluejay Diagnostics Inc. (BJDX:NASDAQ), 46.36%
- Homology Medicines, Inc. (FIXX:NASDAQ), 41.49%
- ASP Isotopes Inc. (ASPI:NASDAQ), 34.44%
- Roku, Inc. (ROKU:NASDAQ), 31.41%
- View Inc. (VIEW:NASDAQ), 30.91%